"The COVID-19 Treatment Guidelines Panel recommends against the use of mesenchymal stem cells (MSCs) for the treatment of COVID-19, except in a clinical trial (AII)."
"In the United States, MSCs should not be used for the treatment of COVID-19 outside of an FDA-approved clinical trial, expanded access programs, or an Emergency Investigational New Drug application (AII).